Teva Pharmaceutical Industries (TEVA) EPS (Diluted) Growth (3y) (2012 - 2026)
Teva Pharmaceutical Industries (TEVA) EPS (Diluted) Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 3.25% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.66% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 11.56% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -35.09% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 13.29% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 36.48% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.07 Bn | 7.41 Bn | 397.90 Mn | -87.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.17% |
| Mar 31, 2026 | 50.12% |
| Dec 31, 2025 | 32.69% |
| Sep 30, 2025 | 86.52% |
| Jun 30, 2025 | 43.68% |
| Mar 31, 2025 | 30.37% |
| Dec 31, 2024 | -21.25% |
| Sep 30, 2024 | -48.23% |
| Jun 30, 2024 | -82.55% |
| Mar 31, 2024 | 84.09% |
| Dec 31, 2023 | -139.38% |
| Sep 30, 2023 | 26.35% |
| Jun 30, 2023 | -102.98% |
| Mar 31, 2023 | -77.63% |
| Dec 31, 2022 | -140.55% |
| Sep 30, 2022 | 30.04% |
| Jun 30, 2022 | 26.51% |
| Mar 31, 2022 | -108.96% |
| Dec 31, 2021 | 99.64% |
| Sep 30, 2021 | 44.69% |